Dermatology · San Jose, CA
NPI
1093718546
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
2050 Clarmar Way
San Jose, CA, 95128
Phone (408) 294-7551
Medicare paid, 2024
$229K
2,946 services
Medicare patients, 2024
440
Average age 75
Drug cost, 2024
$3.2M
2,722 prescriptions
Company payments, 2025
$7,213
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mychael Luu was code 99213 (office e&m - established), 638 times for 273 patients. In total Mychael Luu billed 2,946 services in 70 codes, and Medicare paid $229K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-05-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 638 | 273 | $82.08 | $52K |
| 17003 Destruction Skin Lesion | Office | 623 | 96 | $6.94 | $4,323 |
| 96372 Injection Administration | Office | 302 | 43 | $13.99 | $4,226 |
| 17110 Destruction Skin Lesion | Office | 205 | 133 | $113.42 | $23K |
| 99214 Office E&M - Established | Office | 195 | 106 | $120.68 | $24K |
| 17000 Destruction Skin Lesion | Office | 171 | 112 | $45.50 | $7,781 |
| 99203 Office E&M - New | Office | 107 | 107 | $92.74 | $9,924 |
| 11102 Skin Biopsy | Office | 89 | 79 | $92.23 | $8,208 |
| 99204 Office E&M - New | Office | 46 | 46 | $139.70 | $6,426 |
| 11103 Skin Biopsy | Office | 29 | 24 | $50.64 | $1,469 |
| 99212 Office E&M - Established | Office | 21 | 20 | $56.23 | $1,181 |
| 17311 Mohs Surgery | Office | 20 | 19 | $471.39 | $9,428 |
| 15853 Wound Repair - All Levels | Office | 18 | 17 | $12.90 | $232 |
| 17312 Mohs Surgery | Office | 13 | 11 | $428.58 | $5,572 |
By year: 2022 $187K for 2,353 services; 2023 $186K for 2,276 services; 2024 $229K for 2,946 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87220 General Laboratory | 13 | 13 | $4.18 | $54.34 |
Medicare prescription drug claims, 2024
In 2024, the drug Mychael Luu prescribed most often to Medicare patients was Triamcinolone Acetonide, with 232 prescriptions and refills. In total Mychael Luu wrote 2,722 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 232 | 273 | 97 | $2,944 |
| Ketoconazole Generic | 223 | 242 | 89 | $3,922 |
| Dupixent Pen Dupilumab | 204 | 217 | 26 | $814K |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 202 | 216 | 76 | $8,208 |
| Clobetasol Propionate Generic | 180 | 189 | 73 | $7,959 |
| Fluocinonide Generic | 141 | 153 | 53 | $6,444 |
| Mirtazapine Generic | 104 | 253 | 50 | $2,207 |
| Ciclopirox Generic | 86 | 90 | 41 | $1,754 |
| Fluticasone Propionate Generic | 85 | 92 | 44 | $2,090 |
| Levocetirizine Dihydrochloride Generic | 66 | 148 | 28 | $832 |
| Fluocinolone Acetonide Generic | 65 | 71 | 36 | $3,916 |
| Mometasone Furoate Generic | 64 | 66 | 30 | $1,186 |
| Betamethasone Dipropionate Generic | 54 | 61 | 35 | $1,988 |
| Hydrocortisone Generic | 51 | 66 | 25 | $470 |
| Metronidazole Generic | 48 | 65 | 20 | $2,700 |
Brand drugs: 537 claims; generic drugs: 2,185 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mychael Luu $7,213 ($7,213 in general payments such as food, travel and fees) from 19 companies. The largest payer was Galderma Laboratories, L.P. with $1,096.
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. GALD.SW | 23 | $1,096 |
| Abbvie Inc. ABBV | 32 | $852 |
| Janssen Biotech, Inc. JNJ | 22 | $766 |
| UCB, Inc. UCB.BR | 24 | $588 |
| Regeneron Healthcare Solutions, Inc. REGN | 19 | $541 |
| Incyte Corporation INCY | 17 | $469 |
| Genzyme Corporation SNY | 11 | $459 |
| Lilly USA, LLC LLY | 12 | $441 |
| Novartis Pharmaceuticals Corporation NVS | 18 | $370 |
| LEO Pharma Inc. | 16 | $358 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.